Role of zoledronic acid in the prevention and treatment of osteoporosis

Código QR

Role of zoledronic acid in the prevention and treatment of osteoporosis

Agnès Räkel, Andrée Boucher, Louis-Georges Ste-MarieEndocrinology, Department of Medicine. Centre de recherche du CHUM, Université de Montréal, Montréal, QC, CanadaAbstract: Taken once a year, intravenous zoledronic acid (Zol) (Reclast&...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Räkel A, Boucher A, Ste-Marie L-G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Zoledronic acid osteoporosis elderly. Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/ab0974cfecea4416af1a7e6ac9610e07
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Paul K Piper Jr, et al.
Publicado: (2009)

Once-yearly zoledronic acid in hip fracture prevention
por: Oddom Demontiero, et al.
Publicado: (2009)

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
por: Wang Z, et al.
Publicado: (2021)

Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
por: Shi C, et al.
Publicado: (2018)

A review of minodronic acid hydrate for the treatment of osteoporosis
por: Tanishima S, et al.
Publicado: (2013)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Masashi Uehara, et al.
Publicado: (2021)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Tahir Masud, et al.
Publicado: (2009)

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
por: Irene Lambrinoudaki, et al.
Publicado: (2008)

Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage
por: Siris ES, et al.
Publicado: (2015)

Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D
por: Federica Bellone, et al.
Publicado: (2021)

Diagnosis and management of osteoporosis in the older senior
por: Sheryl F Vondracek, et al.
Publicado: (2009)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
por: Peker N, et al.
Publicado: (2018)

Pharmacological treatment of osteoporosis in the oldest old
por: Vandenbroucke A, et al.
Publicado: (2017)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
por: Claudia Gagnon, et al.
Publicado: (2008)

Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update
por: Nagy EE, et al.
Publicado: (2020)

Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009)

BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women
por: Ma Z, et al.
Publicado: (2016)

Potential underdiagnosis of osteoporosis in repeated vertebral augmentation for new vertebral compression fractures
por: İlhan B, et al.
Publicado: (2015)

Olive oil in the prevention and treatment of osteoporosis after artificial menopause
por: Liu HL, et al.
Publicado: (2014)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
por: Victor G Vogel
Publicado: (2008)

Bone cement distribution in the vertebral body affects chances of recompression after percutaneous vertebroplasty treatment in elderly patients with osteoporotic vertebral compression fractures
por: Zhang L, et al.
Publicado: (2017)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle OA, et al.
Publicado: (2018)

Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats
por: Chin KY, et al.
Publicado: (2014)

Treatment of primary osteoporosis in men
por: Giusti A, et al.
Publicado: (2014)

Awareness of osteoporosis and its relationship with calcaneus quantitative ultrasound in a large Chinese community population
por: Xu J, et al.
Publicado: (2013)

Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study
por: Fan Z, et al.
Publicado: (2020)

Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study
por: Fan T, et al.
Publicado: (2013)

Fracture prevention service to bridge the osteoporosis care gap
por: Ruggiero C, et al.
Publicado: (2015)

Epidemiology and management of osteoporosis in the People’s Republic of China: current perspectives
por: Lin X, et al.
Publicado: (2015)

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate H, et al.
Publicado: (2011)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Hisaya Kawate, et al.
Publicado: (2010)

Eldecalcitol for the treatment of osteoporosis
por: Noguchi Y, et al.
Publicado: (2013)

Specific higher levels of serum uric acid might have a protective effect on bone mineral density within a Chinese population over 60 years old: a cross-sectional study from northeast China
por: Chen F, et al.
Publicado: (2019)

Fracture liaison services: improving outcomes for patients with osteoporosis
por: Walters S, et al.
Publicado: (2017)

Teriparatide in the management of osteoporosis
por: Donald Bodenner, et al.
Publicado: (2008)

lncRNA GAS5 Is Upregulated in Osteoporosis and Downregulates miR-21 to Promote Apoptosis of Osteoclasts
por: Cong C, et al.
Publicado: (2020)

The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
por: Baccaro LF, et al.
Publicado: (2015)

Osteoporosis screening and risk management
por: Consuelo H Wilkins
Publicado: (2007)

Clinical challenges in the management of osteoporosis
por: Sheryl F Vondracek, et al.
Publicado: (2008)